Advertisement

Topics

MaxCyte, Inc Company Profile

10:24 EDT 26th September 2018 | BioPortfolio

MaxCyte is a clinical-stage cell therapeutics company with a growing pipeline of proprietary and partnered drug candidates. Programs in development are based on MaxCyte's platform technology which breaks down the barriers to ex vivo cell loading and the manufacture of viral vectors. MaxCyte's pipeline includes one product in Phase I/II clinical trials for the treatment of Chronic Lymphocytic Leukemia (CLL) and several preclinical candidates to treat a variety of diseases with unmet needs. The company also offers its unparalleled, customizable technology to collaborators who take advantage of its advanced capabilities for cell-based therapeutic development and biotherapeutic manufacturing. Partners are currently working to develop therapeutics for pulmonary disease, congenital heart disease and cancer

Location

22 Firstfield Road, Suite 250
Gaithersburg
Maryland
20878
United States of America

Contact

Phone: 301-944-1700
Fax: (301) 944-1703
Email: info@maxcyte.com


News Articles [15 Associated News Articles listed on BioPortfolio]

MaxCyte on track to start first-ever clinical trial before the end of the year

The phase I clinical study will evaluate the safety of MaxCyte's MCY-M11 chimeric antigen receptor in people with relapsed or difficult-to-treat ovarian cancer and peritoneal mesothelioma

MaxCyte receives FDA approval to start Phase I study of MCY-M11

MaxCyte has received investigational new drug (IND) approval from the US Food and Drug Administration (FDA) to initiate a Phase...Read More... The post MaxCyte receives FDA approval to start Phase I s...

MaxCyte CEO Says FDA OK Of IND For Its CAR Receptor Candidate Major Milestone

MaxCyte's first next-generation chimeric antigen receptor MCY-M11 will be studied in solid tumors.    

MaxCyte gets US FDA clearance to begin clinical study of CAR therapeutic candidate, MCY─M11

MaxCyte, a global cell─based medicines and life sciences company, has received Investigational New Drug (IND) clearance from the US Food and Drug Administration (FDA) to begin a clinical study in th...

NIH and MaxCyte to develop new sickle cell disease therapies

The US National Institutes of Health (NIH) has signed a cooperative research and development agreement (CRADA) with life sciences company...Read More... The post NIH and MaxCyte to develop new sickle ...

MaxCyte gets green light for solid tumour cell therapy

Its first CAR therapy will be tested in patients with ovarian cancer

MaxCyte hails US National Institutes of Health tie-up to find treatment for sickle cell disease

The collaboration will be with National Heart, Lung and Blood Institute, which is part of the NIH

MaxCyte gears up for first clinical trial after gaining regulatory green light

The US Food & Drug Administration has given the company investigational new drug clearance for MCY-M11, a chimeric antigen receptor that targets solid tumours

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

MaxCyte, Inc.

MaxCyte specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of innovative therapeutic products. Drawing on its cell the...

MaxCyte, Inc

MaxCyte is a clinical-stage cell therapeutics company with a growing pipeline of proprietary and partnered drug candidates. Programs in development are based on MaxCyte's platform technology which bre...

MEDINET Co., Ltd. and MaxCyte, Inc.

MEDINET is a world leading company in cell therapy, supporting medical service providers in Japan. Through its service, MEDINET provides medical institutions with advanced technol...

More Information about "MaxCyte, Inc" on BioPortfolio

We have published hundreds of MaxCyte, Inc news stories on BioPortfolio along with dozens of MaxCyte, Inc Clinical Trials and PubMed Articles about MaxCyte, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MaxCyte, Inc Companies in our database. You can also find out about relevant MaxCyte, Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record